Cycloud Bio announce strategic corporation with Stilla Technologies

Beijing Cycloud Biotechnology Co., Ltd. signed strategic cooperation and agency agreement lately with Stilla Technologies, starting the promotion, sales, service, and relating technical application jobs of Naica™ crystal new generation digital PCR system in China area.

Naica™ crystal digital PCR system is a revolutionary product launched by the Stilla Technologies from France, creatively grouped the uniformity of micro-droplets, and chip visualization and according reaction conditions into the one single system, which not only fulfills the need of accuracy, and repeatability, but also allows the digital PCR molecular testingto become more simple, and quick.

Naica™ crystal digital PCR system achieved a compact, easy to use, quick, and reliable digital PCR solutions, including:

₋ Fully enclosed: Sample is joined with special chip and sealed entirely. No cross-contamination.

- Micro-flow device: The sample automatically generates and tiles 25000-30000 uniform droplets.

₋3-color channels：FAM…/VIC…/Cy5…three fluorescence channels for multiplex assay

₋crystal droplets inspection：visual inspection to the single droplet

-compatible with Evagreen, TaqMan probe and the likewise fluorescence assay

“We are very pleased with the performance of Naica™ crystal digital PCR system, able to fully fulfills our need of accuracy and repeatability, along with its convenient operation, direct software, and fast data analysis,” Europe leading Gustave Roussy director, Ludovic LACROIX master commented the Naica system.

Stilla Technologies BD director, Caroline Charky, mentioned in a letter, “We are very happy to be able to further promote our new generation digital PCR technology, and have marketing cooperation with Beijing CycloudBio Co., Ltd. We can anticipate the success of our cooperation.”

“Very happy to be able to promote the Naica™ crystal digital PCR system, a innovative platform, with the Stilla. Coming the the town of innovation and fashion, Paris, the product will indeed bring surprise to the Chinese customers!” said the national sales manager of Beijing Cycloud Biotechnology Co., Ltd., Li Chi, “digital PCR is the hot spot of the current market, and I and our team are well-prepared for this product to enter China. It is our responsibilities to allow Chinese customers to use the best product, and to experience the best service. Also thank you the Stilla team for trusting us.”

Beijing Cycloud Biotechnology Co., Ltd. digital PCR product science advisor, Beijing ApexBio ltd. research and develop director, Doctor Jian Gong, said, “The Naica™ crystal new generation digital OCR system is compatible with the advantages of digital PCR system in the market, avoids the disadvantages, and has extremely important meaning to trace nucleic acid detection, rare mutations detection, copy number variation, single-gene expression analysis, and etc. research fields. Moreover, Naica is even more suitable for application such as, cfDNA, infectious disease detection, cancer early diagnosis, prognosis and follow-up, and organ transplantation exclusiveness detection etc, making the detection data to be more traceable. Also, the unique third Cy5 fluorescent detection venue, which is the first time for the digital PCR products’ connection with BEAMing technique. We believe that the Stilla Naica™ crystal new generation digital PCR application technology laboratory, responsible by us, will benefit more Chinese scientist, and Chinese corporation.”

About Stilla Technologies：

Stilla Technologies is a Paris-based European biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing biologists with tools for high-resolution genetic analysis. Using breakthrough microfluidic technology, Stilla has developed the Naica system, an innovative digital PCR platform compatible with multiple chemistries and equipped with multiplex capabilities. Most of all, by encapsulating all steps for digital PCR in a single chip, Naica offers a fast and user friendly solution, rendering digital PCR accessible to all.

For more information: www.stilla.fr

About CycloudBIO:

Beijing Cycloud Biotechnology Co., Ltd. is committed to providing users with the latest life science research-instruments and analytic products, along with optimized, overall solutions. Cycloud Bio, possessing professional technical and application support, and relying on the world's cutting-edge life science products and solutions, focuses on providing analytical products with complete pre-sales consultation and after-sales service for clients. Cycloud BioTech has also been the China regional technologic application and demonstration center of Azure Biosystems, and Echo Laboratories.

For more information www.cycloudbio.com